The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Demand for GLP-1 drugs is causing spending on traditional ... But despite the drugs’ potential to ameliorate obesity and other chronic conditions, the cost of GLP-1s is adding more accelerant ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching artificial intelligence and emerging ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

More Type 1 Diabetics Are Obese, Taking GLP-1 Drugs By Dennis Thompson HealthDay Reporter MONDAY, March 31, 2025 (HealthDay News) -- Use of cutting-edge weight-loss drugs like Ozempic and Zepbound ...